Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early circulating erythroid progenitors (BFU-E) in sickle cell anemia

H Croizat1

  • 1Albert Einstein College of Medicine, Bronx, New York 10461.

Experientia
|February 15, 1993
PubMed
Summary

Sickle cell anemia patients with low fetal hemoglobin (HbF) levels show increased BFU-E activity and constitutive GM-CSF production. High HbF levels correlate with inhibitory factors and distinct BFU-E responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized.

British journal of haematology·2000
Same author

Embryonic stem cells release potentially novel hematopoietic factors.

Acta haematologica·2000
Same author

Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis.

Transplantation·1999
Same author

Studies of erythroid burst-forming units in patients with posttransplant erythrocytosis.

Transplantation proceedings·1999
Same author

Circulating cytokines response and the level of erythropoiesis in sickle cell anemia.

American journal of hematology·1999
Same author

Circulating cytokines in sickle cell patients during steady state.

British journal of haematology·1994

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Sickle cell anemia (SS) patients exhibit heterogeneous peripheral blood fetal hemoglobin (HbF) levels, influencing disease pathophysiology.
  • Two distinct subpopulations exist: low HbF (LFSS) with high burst-forming unit-erythroid (BFU-E) activity and high HbF (HFSS) with normal BFU-E characteristics.
  • Further heterogeneity is observed in growth factor responsiveness and adherent cell activity between LFSS and HFSS groups.

Purpose of the Study:

  • To investigate the distinct characteristics of BFU-E and adherent cells in LFSS versus HFSS patients.
  • To elucidate the role of growth factors like GM-CSF and IL-3 in regulating BFU-E proliferation in sickle cell anemia.
  • To understand the factors contributing to the heterogeneity of BFU-E regulation in sickle cell disease.

Main Methods:

  • Analysis of peripheral BFU-E numbers and DNA synthesis.
  • Assessment of burst promoting activity (BPA) release by low-density (LD) adherent cells.
  • Culture experiments involving monocyte-derived cells and conditioned media (CM) from SS patients.
  • Evaluation of BFU-E responsiveness to granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3).

Main Results:

  • LFSS patients display increased circulating BFU-E in active synthesis, with BPA release from unstimulated LD adherent cells.
  • HFSS patients have normal BFU-E numbers, with LD cells not releasing BPA; their CM inhibits BFU-E expression.
  • LFSS BFU-E are equally responsive to GM-CSF and IL-3, while HFSS BFU-E include a subset exclusively dependent on IL-3, similar to normal individuals.

Conclusions:

  • LFSS patients exhibit an actively proliferating BFU-E population regulated by constitutive GM-CSF and potentially other factors.
  • HFSS patients' adherent cells may release inhibitory factors, contributing to distinct BFU-E regulation.
  • BFU-E heterogeneity in sickle cell disease appears to be an epiphenomenon of HbF levels, reflecting varying hemopoietic stress.

Related Experiment Videos